April 21, 2026
Washington, D.C. – The Natural Products Association condemned a deeply flawed and unnecessary bill introduced in the United States House of Representatives, warning that it would impose sweeping new federal burdens on dietary supplement manufacturers at the very moment the industry is confronting an accelerating wave of state-level efforts to restrict consumer access.
The Dietary Supplement Listing Act would require manufacturers to register their products with FDA, despite the absence of any credible evidence that FDA lacks the authority or information today to effectively oversee the marketplace and protect public health. The proposal is premised on a false narrative that the agency operates in the dark. In reality, FDA already possesses extensive tools to monitor safety, enforce compliance, remove dangerous products from U.S. commerce, and target bad actors through civil and criminal actions.
Beyond being unnecessary, the legislation would require FDA to build and maintain a centralized electronic database of dietary supplement products, a move that risks transforming regulatory compliance into a litigation trap. This database would certainly be weaponized by plaintiff’s attorneys to pursue opportunistic claims based on highly technical or unsettled interpretations of FDA law and state consumer protection statutes, creating significant legal exposure for companies acting in good faith.
“This misguided bill would only divert critical resources away from scientific research, product innovation and quality improvements, ultimately slowing development of the next generation of dietary supplements that consumers rely on to promote their health,” said Daniel Fabricant, Ph.D., president and CEO of NPA. “At a time when U.S. policymakers should be focused on clarifying regulations and strengthening federal uniformity, this bill is in search of a problem and would create unnecessary requirements, increase the risks of frivolous litigation, and undermine innovation across the industry.”
On May 12, 2026, NPA members will come to Washington, D.C., for NPA’s Fly-In Day to advocate for common-sense policies that promote public health and reaffirm FDA’s authority to regulate dietary supplements under a uniform, national framework.
During Fly-In Day, NPA will focus its efforts on supporting:
- The Dietary Supplement Regulatory Uniformity Act, which would prevent states from imposing conflicting and restrictive requirements on dietary supplements that undermine federal oversight and limit consumer access to these products.
- Legislative reform of the clause in DSHEA (Dietary Supplement Health and Education Act of 1994) that creates a race to market between dietary supplements and FDA-approved or investigated drugs. As interpreted by FDA, the drug preclusion clause has created confusion about the legality of dietary supplement products in the U.S. market and threatened to impede ingredient innovation.
- Expanding consumer access to dietary supplement products through health savings and flexible spending accounts, through legislation or reforms in the executive branch.
- Opposition to mandatory product listing, which would not only undermine investments in science but also frustrate efforts to block state legislators from burdening manufacturers with age-gating restrictions.
Dietary supplement policy should be grounded in science, risk-based oversight and regulatory consistency, not duplicative or otherwise unwarranted mandates that burden the industry while doing little to address the real sources of consumer harm. NPA has launched a grassroots campaign where industry advocates are encouraged to write to their members of Congress, requesting that they oppose mandatory product listing.
For media inquiries, contact Josh Long at jlong@npanational.org.
